| Income Statement | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
| Sales | 476,705 | 610,864 | 502,568 | 627,750 |
| Cost of sales | 127,788 | 138,315 | 244,127 | 273,981 |
| Gross profit | 348,917 | 472,549 | 258,441 | 353,769 |
| Selling, general and administrative expenses | 872,797 | 541,731 | 621,641 | 498,198 |
| Total operating expenses | 872,797 | 541,731 | 621,641 | 498,198 |
| Loss from operations | -523,880 | -69,182 | -363,200 | -144,429 |
| Amortization of debt issuance costs and discounts | - | - | - | 0 |
| Interest expense | 36,352 | 41,735 | 92,149 | 37,202 |
| Other income | - | - | -77 | 19,653 |
| Deconsolidation, gain (loss), amount | - | - | - | 0 |
| Equity securities, fv-ni, gain (loss) | - | - | - | 0 |
| Total other income (expense) | -36,352 | -41,735 | -92,226 | -17,549 |
| Loss before provision for income taxes | -560,232 | -110,917 | -455,426 | -161,978 |
| Provision for income taxes | 0 | - | - | 0 |
| Net loss | -560,232 | -110,917 | -455,426 | -161,978 |
| Deemed dividend for down-round provision in warrants | 0 | - | - | 0 |
| Preferred stock dividends | 71,227 | - | - | - |
| Net loss attributed to common stockholders | -631,459 | -110,917 | -455,426 | -161,978 |
| Loss per shares - basic (in dollars per share) | -0.01 | 0 | -0.01 | 0 |
| Loss per shares - diluted (in dollars per share) | -0.01 | 0 | -0.01 | 0 |
| Weighted average shares outstanding - basic (in shares) | 57,309,903 | 47,913,673 | 45,498,061 | 42,526,088 |
| Weighted average shares outstanding - diluted (in shares) | 57,309,903 | 47,913,673 | 45,498,061 | 42,526,088 |
US NUCLEAR CORP. (UCLE)
US NUCLEAR CORP. (UCLE)